TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21540372

Group type: EXPERIMENTAL
Intervention: Indoor Residual Spraying (IRS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Insecticide-Treated Nets (ITNs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Environmental Management (EVM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Intervention
Number of subjects: 40
Study: 19453964

Group type: EXPERIMENTAL
Intervention: Caucasian male patient scenario with Blue Cross health insurance
Number of subjects: 90

Group type: COMPARATOR
Intervention: African American male patient scenario with Medicaid
Number of subjects: 90
Study: 16928441

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15301924

Group type: EXPERIMENTAL
Intervention: Progesterone (200 mg, two oral doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11552858

Group type: EXPERIMENTAL
Intervention: Physiotherapy during the intubated phase
Number of subjects: 236

Group type: COMPARATOR
Intervention: Physiotherapy commenced only once extubated (Control)
Number of subjects: 236
Study: 9204360

Group type: EXPERIMENTAL
Intervention: iopentol
Number of subjects: 80

Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 80
Study: 8491638

Group type: EXPERIMENTAL
Intervention: Intensive intervention
Number of subjects: 612

Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 612

Group type: COMPARATOR
Intervention: Control
Number of subjects: 612
Study: 3325256

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with ofloxacin during granulocytopenia after cytostatic treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control phases (no ofloxacin prophylaxis) during cytostatic treatment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with ofloxacin
Number of subjects: 42
Study: 28732068

Group type: EXPERIMENTAL
Intervention: Primaquine (PQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: PQ and Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed-species infections
Number of subjects: 0
Study: 26276922

Group type: EXPERIMENTAL
Intervention: Body modifications (tattoos or piercings)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Control group (no body modifications)
Number of subjects: 449
Study: 24626975

Group type: EXPERIMENTAL
Intervention: Phonological remediation program associated with reading and writing (GI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (GII)
Number of subjects: 20
Study: 21355965

Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound training using a simulator (15 cases)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Endobronchial ultrasound training using patients (15-25 cases)
Number of subjects: 13
Study: 18652710

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 20
Study: 16865084

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 6% (HAES)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Albumin 20% (HA)
Number of subjects: 20
Study: 14662531

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Vein resection
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard resection
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Overall survival in patients with ductal adenocarcinoma
Number of subjects: 149
Study: 11053009

Group type: EXPERIMENTAL
Intervention: 325 mg aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 81 mg aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8764801

Group type: EXPERIMENTAL
Intervention: Contact diode laser transscleral cyclophotocoagulation (TSCPC)
Number of subjects: 27
Study: 1417485

Group type: EXPERIMENTAL
Intervention: Ultrasonic dissector
Number of subjects: 73

Group type: COMPARATOR
Intervention: Electrosurgery
Number of subjects: 73

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 73
Study: 2435449

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Stepwise scheme (including imipramine, amitriptyline, mianserin, phenothiazine, clonazepam)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Imipramine or amitriptyline (150 mg)
Number of subjects: 80
Study: 31604654

Group type: EXPERIMENTAL
Intervention: Enlarged left atrial volume index (eLAVI)
Number of subjects: 1534
Study: 29508373

Group type: EXPERIMENTAL
Intervention: EHBM subscale - Self-efficacy
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: EHBM subscale - Perceived benefits
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: EHBM subscale - Perceived barriers
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: EHBM subscale - Perceived severity
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: EHBM subscale - Parental knowledge
Number of subjects: 1016
Study: 26767629

Group type: EXPERIMENTAL
Intervention: Active vitamin D3 (cholecalciferol; 2000 IU/d) and active marine omega‐3 fatty acids (Omacor® fish oil, eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA], 1g/d)
Number of subjects: 25874

Group type: COMPARATOR
Intervention: Active vitamin D and omega‐3 placebo
Number of subjects: 25874

Group type: EXPERIMENTAL
Intervention: Vitamin D placebo and active marine omega‐3 fatty acids
Number of subjects: 25874

Group type: COMPARATOR
Intervention: Vitamin D placebo and omega‐3 placebo
Number of subjects: 25874
Study: 24619062

Group type: EXPERIMENTAL
Intervention: High Pressure (n=147) - MAP maintained between 75-85 mmHg during CPB with norepinephrine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (n=145) - MAP maintained between 50-60 mmHg
Number of subjects: 300
Study: 22258266

Group type: EXPERIMENTAL
Intervention: Energy-reduced diets emphasizing fat, protein, or carbohydrate
Number of subjects: 424
Study: 20108108

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate and glucosamine (1,600 mg oral mixture, twice daily for 8 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (twice daily for 8 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison between experimental and control groups
Number of subjects: 80
Study: 17588298

Group type: EXPERIMENTAL
Intervention: Quarter-dose titration and acetaminophen
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Quarter-dose titration and ibuprofen
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Half-dose titration and acetaminophen
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Half-dose titration and ibuprofen
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Full-dose therapy plus acetaminophen
Number of subjects: 47

Group type: COMPARATOR
Intervention: No titration (control group)
Number of subjects: 47
Study: 16305583

Group type: EXPERIMENTAL
Intervention: Artemisinin
Number of subjects: 0
Study: 12160284

Group type: EXPERIMENTAL
Intervention: 0.05% xylometazoline hydrochloride (five drops)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 10441974

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate via nebulizers at a dosage of 2 mg twice daily for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 8527276

Group type: EXPERIMENTAL
Intervention: Colestipol ('Colestid Orange')
Number of subjects: 55

Group type: COMPARATOR
Intervention: Low dose cholestyramine ('Questran A')
Number of subjects: 55
Study: 2611301

Group type: EXPERIMENTAL
Intervention: Rocking (15-min sessions of sinusoidal oscillation, three times a day for 2 weeks)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rocking
Number of subjects: 26
Study: 786680

Group type: EXPERIMENTAL
Intervention: Ibuprofen (Brufen: 400 mg three times daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30711183

Group type: EXPERIMENTAL
Intervention: Aluminum chloride
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electrocauterization
Number of subjects: 60
Study: 28456141

Group type: EXPERIMENTAL
Intervention: HPV infection
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Hormone use
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Lesions
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: HPV types
Number of subjects: 61
Study: 26074708

Group type: EXPERIMENTAL
Intervention: Levofloxacin-doxycycline-based triple therapy with Lactobacillus casei DG (n = 71)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Levofloxacin-doxycycline-based triple therapy without Lactobacillus casei DG (n = 71)
Number of subjects: 142
Study: 22884235

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 12
Study: 21234550

Group type: EXPERIMENTAL
Intervention: Nicotine patch (NIC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo patch (PL)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Smoke as normal (SM)
Number of subjects: 49
Study: 19904668

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 158
Study: 17095973

Group type: EXPERIMENTAL
Intervention: Inhaled nitroglycerin (20 microg.kg(‐1))
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Inhaled iloprost (2.5 microg.kg(‐1))
Number of subjects: 100
Study: 15155607

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 200 micro g
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 400 micro g
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 800 micro g
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12394656

Group type: EXPERIMENTAL
Intervention: rhBMP-2 on an absorbable collagen sponge
Number of subjects: 279

Group type: COMPARATOR
Intervention: Autogenous iliac crest bone graft
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 279
Study: 9607605

Group type: EXPERIMENTAL
Intervention: Recombinant antileukoprotease (rALP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7614199

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 19
Study: 2198075

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (VCMP/VBAP)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Melphalan-prednisone (MP)
Number of subjects: 386
Study: 369076

Group type: EXPERIMENTAL
Intervention: Ciclobendazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ciclobendazole (600 mg to 1200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mebendazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ciclobendazole and Mebendazole
Number of subjects: 0
Study: 31361675

Group type: EXPERIMENTAL
Intervention: Patient-reported outcome measures (PROMs) intervention
Number of subjects: 0
Study: 31449829

Group type: EXPERIMENTAL
Intervention: PACAP27 (10 pmol/kg/min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PACAP27
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PACAP38
Number of subjects: 18
Study: 28412302

Group type: COMPARATOR
Intervention: Stage tailored intervention (ST)
Number of subjects: 1243
Study: 25590980

Group type: EXPERIMENTAL
Intervention: VICKY
Number of subjects: 70

Group type: COMPARATOR
Intervention: MFHP
Number of subjects: 70
Study: 24227738

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of hMT
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of hMST
Number of subjects: 1
Study: 21873443

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of the bradykinin B(2) receptor antagonist, HOE‐140 (100 μg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HOE‐140
Number of subjects: 20
Study: 19362800

Group type: EXPERIMENTAL
Intervention: Automated telephone reminders (ATRs)
Number of subjects: 3547

Group type: COMPARATOR
Intervention: Printed enhanced usual care reminders (EUCRs)
Number of subjects: 3547

Group type: EXPERIMENTAL
Intervention: Enhanced letter reminders
Number of subjects: 3547
Study: 17186430

Group type: EXPERIMENTAL
Intervention: Postoperative nasogastric or nasojejunal tube (Tube Group, n = 43)
Number of subjects: 84

Group type: COMPARATOR
Intervention: No tube (No‐tube Group, n = 41)
Number of subjects: 84
Study: 15076014

Group type: EXPERIMENTAL
Intervention: 30 mg adjunctive mirtazapine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11222419

Group type: EXPERIMENTAL
Intervention: Nurse-led unit
Number of subjects: 238

Group type: COMPARATOR
Intervention: Usual post-acute care
Number of subjects: 238
Study: 9759798

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg bid
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Terbutaline 500 microg qid
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg bid and Terbutaline 500 microg qid
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 343
Study: 7827322

Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 4
Study: 30835436

Group type: EXPERIMENTAL
Intervention: Bicarbonate (0.40 g/kg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 28233458

Group type: COMPARATOR
Intervention: β-blocker treatment
Number of subjects: 5242

Group type: COMPARATOR
Intervention: β1-/β2-receptor-blockers (n=2219)
Number of subjects: 5242

Group type: COMPARATOR
Intervention: High-dose β-blockers (>25 mg carvedilol equivalent daily dose, n=1005)
Number of subjects: 5242
Study: 26254013

Group type: EXPERIMENTAL
Intervention: Miniaturized multiplane TEE probe
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard TEE probe
Number of subjects: 57
Study: 23757424

Group type: EXPERIMENTAL
Intervention: EX50 (50% VO2peak)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: EX65 (65% VO2peak)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: EX50
Number of subjects: 11

Group type: COMPARATOR
Intervention: EX65
Number of subjects: 11

Group type: COMPARATOR
Intervention: CON (control trial)
Number of subjects: 11
Study: 21270723

Group type: EXPERIMENTAL
Intervention: Sequential injection of 1.5% mepivacaine followed 90 secs later by 0.5% ropivacaine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Simultaneous injection of 1.5% mepivacaine and 0.5% ropivacaine
Number of subjects: 103
Study: 19922129

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 19
Study: 16509104

Group type: EXPERIMENTAL
Intervention: Passive meaningless gestures applied to RHDP with neglect
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Passive meaningless gestures applied to RHDP without neglect
Number of subjects: 40

Group type: COMPARATOR
Intervention: Passive meaningless gestures applied to LHDP
Number of subjects: 40

Group type: COMPARATOR
Intervention: Passive meaningless gestures applied to controls
Number of subjects: 40
Study: 12599012

Group type: EXPERIMENTAL
Intervention: (99m)Tc-anti-CD66 mAb BW 250/183
Number of subjects: 12

Group type: COMPARATOR
Intervention: (99m)Tc-anti-CD45 mAb YTH 24.5
Number of subjects: 12
Study: 10689268

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (30 mg/kg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 28
Study: 9577225

Group type: EXPERIMENTAL
Intervention: Pain patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Student control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychiatric patients
Number of subjects: 0
Study: 8451143

Group type: EXPERIMENTAL
Intervention: Massed Practice group (no rests)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Distributed Practice group (1 min. rest after each 1 min. of viewing)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Massed Practice group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Distributed Practice group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Boys in Trial 3
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rigidity scores
Number of subjects: 24
Study: 3534847

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canrenoate potassium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study: 30174281

Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg
Number of subjects: 252

Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 252
Study: 29933529

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sodium diclofenac (SD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 25465826

Group type: EXPERIMENTAL
Intervention: Meteorological events classified as temperature changes in the 7 days prior to AHF event.
Number of subjects: 7141
Study: 22338035

Group type: EXPERIMENTAL
Intervention: SFA meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PUFA meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MUFA meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PUFAs
Number of subjects: 10
Study: 20384753

Group type: EXPERIMENTAL
Intervention: KTP laser treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrocoagulation (EC) treatment
Number of subjects: 0
Study: 18413464

Group type: EXPERIMENTAL
Intervention: Baseline serum urate concentration (top quintile)
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Baseline serum urate concentration (men)
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Baseline serum urate concentration (women)
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Change in striatal [(123)I]beta-CIT uptake
Number of subjects: 804
Study: 15716163

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First-degree biological relatives of schizophrenia patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonpsychiatric controls
Number of subjects: 0
Study: 12012078

Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg x day(‐1))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10426452

Group type: EXPERIMENTAL
Intervention: Single-agent docetaxel (Taxotere) 100 mg/m2 every 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination chemotherapy regimens (mitomycin C plus vinblastine, methotrexate plus 5‐fluorouracil, or 5‐fluorouracil plus vinorelbine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-agent docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-agent doxorubicin
Number of subjects: 0
Study: 7472542

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy on the recently symptomatic artery
Number of subjects: 659

Group type: COMPARATOR
Intervention: Medically treated patients with an occluded contralateral artery
Number of subjects: 659

Group type: COMPARATOR
Intervention: Medically treated patients with mild-to-moderate contralateral artery stenosis
Number of subjects: 659

Group type: COMPARATOR
Intervention: Patients with an occluded contralateral artery
Number of subjects: 659

Group type: COMPARATOR
Intervention: Patients with mild-to-moderate contralateral stenosis
Number of subjects: 659
Study: 1690970

Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sulfasalazine (after 4 additional weeks)
Number of subjects: 50
Study: 477212

Group type: EXPERIMENTAL
Intervention: Ethanol ingestion
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Salivary ethanol measurement
Number of subjects: 32
Study: 31538401

Group type: EXPERIMENTAL
Intervention: StandingTall exercise program delivered through tablet computers for 12 weeks
Number of subjects: 15
Study: 31763287

Group type: EXPERIMENTAL
Intervention: Middle turbinate resection (Group I)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No middle turbinate resection (Group II)
Number of subjects: 31
Study: 28183567

Group type: EXPERIMENTAL
Intervention: Thyromental height measurement test (TMH)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Thyromental distance measurement test (TMD)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Modified Mallampati test (MMT)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Upper lip bite test (ULBT)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Intubation difficulty scale (IDS)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Cormack-Lehane scores (C‐L)
Number of subjects: 451
Study: 24755729

Group type: EXPERIMENTAL
Intervention: Active TMS (n = 7)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation (n = 11)
Number of subjects: 19
Study: 25069199

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study: 22188311

Group type: EXPERIMENTAL
Intervention: Daily topiramate
Number of subjects: 76

Group type: COMPARATOR
Intervention: Pre-emptive frovatriptan
Number of subjects: 76
Study: 19958429

Group type: EXPERIMENTAL
Intervention: 5% niacinamide plus 1% N-undecylenoyl phenylalanine formulation
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 5% niacinamide formulation
Number of subjects: 140

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 140
Study: 17572907

Group type: EXPERIMENTAL
Intervention: Transthoracic Doppler echocardiography (TTDE) with adenosine (140 gamma/kg/min x 3-6 min)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Doppler-wire (DW) with intracoronary adenosine (40 gamma bolus)
Number of subjects: 5